Rennova Health, Inc. (RNVA)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2022 | 6.26 Million USD | 403.03% |
| 2021 | -2.06 Million USD | 54.87% |
| 2020 | -4.58 Million USD | -501.46% |
| 2019 | 1.14 Million USD | -62.43% |
| 2018 | 3.03 Million USD | -17.2% |
| 2017 | 3.67 Million USD | 3.4% |
| 2016 | 3.54 Million USD | -60.79% |
| 2015 | 9.05 Million USD | 2025.21% |
| 2014 | 426 Thousand USD | -14.8% |
| 2013 | 500 Thousand USD | 45.35% |
| 2012 | 344 Thousand USD | 244.0% |
| 2011 | 100 Thousand USD | 525.0% |
| 2010 | 16 Thousand USD | 100.48% |
| 2009 | -3.34 Million USD | -164.33% |
| 2008 | 5.19 Million USD | -62.91% |
| 2007 | 14.01 Million USD | 153.56% |
| 2006 | 5.52 Million USD | -8.13% |
| 2005 | 6.01 Million USD | 84.14% |
| 2004 | 3.26 Million USD | -29.7% |
| 2003 | 4.64 Million USD | 7140.91% |
| 2002 | -66 Thousand USD | -100.99% |
| 2001 | 6.67 Million USD | -56.3% |
| 2000 | 15.27 Million USD | 41.58% |
| 1999 | 10.79 Million USD | 7.9% |
| 1998 | 10 Million USD | -48.45% |
| 1997 | 19.4 Million USD | -31.21% |
| 1996 | 28.2 Million USD | -5.69% |
| 1995 | 29.9 Million USD | 38.43% |
| 1994 | 21.6 Million USD | 30.83% |
| 1993 | 16.51 Million USD | -15.16% |
| 1992 | 19.46 Million USD | -18.2% |
| 1991 | 23.79 Million USD | 42.63% |
| 1990 | 16.68 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q1 | 3.06 Million USD | -11.51% |
| 2023 Q2 | 4.55 Million USD | 48.72% |
| 2023 Q3 | 1.73 Million USD | -61.99% |
| 2022 FY | 6.26 Million USD | 403.03% |
| 2022 Q3 | 1 Million USD | -50.73% |
| 2022 Q4 | 3.46 Million USD | 245.28% |
| 2022 Q2 | 2.03 Million USD | 984.12% |
| 2022 Q1 | -230.12 Thousand USD | -139.16% |
| 2021 Q4 | 587.59 Thousand USD | 397.51% |
| 2021 FY | -2.06 Million USD | 54.87% |
| 2021 Q3 | -197.5 Thousand USD | 41.99% |
| 2021 Q1 | -2.24 Million USD | 1.96% |
| 2021 Q2 | -340.45 Thousand USD | 84.85% |
| 2020 FY | -4.58 Million USD | -501.46% |
| 2020 Q1 | -724.74 Thousand USD | -1049.74% |
| 2020 Q2 | -710.35 Thousand USD | 1.99% |
| 2020 Q3 | -855.13 Thousand USD | -20.38% |
| 2020 Q4 | -2.29 Million USD | -168.12% |
| 2019 Q1 | 1.02 Million USD | 12.08% |
| 2019 Q2 | -619.14 Thousand USD | -160.33% |
| 2019 Q3 | 658.26 Thousand USD | 206.32% |
| 2019 Q4 | 76.31 Thousand USD | -88.41% |
| 2019 FY | 1.14 Million USD | -62.43% |
| 2018 FY | 3.03 Million USD | -17.2% |
| 2018 Q1 | -487.7 Thousand USD | -140.38% |
| 2018 Q4 | 915.65 Thousand USD | -45.78% |
| 2018 Q3 | 1.68 Million USD | 83.09% |
| 2018 Q2 | 922.4 Thousand USD | 289.13% |
| 2017 Q2 | 649.98 Thousand USD | -26.46% |
| 2017 Q3 | 1.1 Million USD | 69.98% |
| 2017 Q4 | 1.2 Million USD | 9.32% |
| 2017 Q1 | 883.8 Thousand USD | 331.17% |
| 2017 FY | 3.67 Million USD | 3.4% |
| 2016 FY | 3.54 Million USD | -60.79% |
| 2016 Q1 | 1.31 Million USD | 111.63% |
| 2016 Q2 | 2.66 Million USD | 102.62% |
| 2016 Q3 | -46.01 Thousand USD | -101.73% |
| 2016 Q4 | -382.32 Thousand USD | -730.8% |
| 2015 Q2 | 82 Thousand USD | -43.84% |
| 2015 Q3 | 90 Thousand USD | 9.76% |
| 2015 FY | 9.05 Million USD | 2025.21% |
| 2015 Q1 | 146 Thousand USD | 92.11% |
| 2015 Q4 | -11.3 Million USD | -12657.32% |
| 2014 Q2 | 46 Thousand USD | -26.98% |
| 2014 Q1 | 63 Thousand USD | 231.25% |
| 2014 Q4 | 76 Thousand USD | -51.9% |
| 2014 Q3 | 158 Thousand USD | 243.48% |
| 2014 FY | 426 Thousand USD | -14.8% |
| 2013 Q4 | -48 Thousand USD | -120.6% |
| 2013 Q3 | 233 Thousand USD | -7.54% |
| 2013 Q2 | 252 Thousand USD | -1.95% |
| 2013 Q1 | 257 Thousand USD | 3571.43% |
| 2013 FY | 500 Thousand USD | 45.35% |
| 2012 Q1 | 25 Thousand USD | -34.21% |
| 2012 FY | 344 Thousand USD | 244.0% |
| 2012 Q2 | 25 Thousand USD | 0.0% |
| 2012 Q3 | 55 Thousand USD | 120.0% |
| 2012 Q4 | 7000.00 USD | -87.27% |
| 2011 Q4 | 38 Thousand USD | 100.0% |
| 2011 FY | 100 Thousand USD | 525.0% |
| 2011 Q3 | 19 Thousand USD | 0.0% |
| 2011 Q2 | 19 Thousand USD | 101.0% |
| 2011 Q1 | -1.9 Million USD | -306.38% |
| 2010 Q1 | 1.25 Million USD | 122.6% |
| 2010 Q2 | -231 Thousand USD | -118.47% |
| 2010 Q3 | 1.23 Million USD | 632.9% |
| 2010 Q4 | 925 Thousand USD | -24.86% |
| 2010 FY | 16 Thousand USD | 100.48% |
| 2009 Q1 | 487 Thousand USD | -64.27% |
| 2009 Q4 | -5.53 Million USD | -752.83% |
| 2009 FY | -3.34 Million USD | -164.33% |
| 2009 Q2 | 93 Thousand USD | -80.9% |
| 2009 Q3 | 848 Thousand USD | 811.83% |
| 2008 Q1 | 3.73 Million USD | -15.54% |
| 2008 FY | 5.19 Million USD | -62.91% |
| 2008 Q3 | 1.02 Million USD | -56.12% |
| 2008 Q4 | 1.36 Million USD | 33.5% |
| 2008 Q2 | 2.32 Million USD | -37.66% |
| 2007 Q2 | 1.62 Million USD | -17.08% |
| 2007 Q1 | 1.95 Million USD | 247.44% |
| 2007 FY | 14.01 Million USD | 153.56% |
| 2007 Q4 | 4.42 Million USD | 4.25% |
| 2007 Q3 | 4.24 Million USD | 161.57% |
| 2006 Q2 | 2.49 Million USD | 105.26% |
| 2006 Q1 | 1.21 Million USD | -27.6% |
| 2006 FY | 5.52 Million USD | -8.13% |
| 2006 Q4 | -1.32 Million USD | -155.25% |
| 2006 Q3 | 2.4 Million USD | -3.92% |
| 2005 Q2 | 675 Thousand USD | 1587.5% |
| 2005 FY | 6.01 Million USD | 84.14% |
| 2005 Q1 | 40 Thousand USD | -92.4% |
| 2005 Q4 | 1.68 Million USD | -31.19% |
| 2005 Q3 | 2.44 Million USD | 261.93% |
| 2004 Q2 | 800 Thousand USD | -70.07% |
| 2004 Q3 | 1.9 Million USD | 137.63% |
| 2004 FY | 3.26 Million USD | -29.7% |
| 2004 Q4 | 526 Thousand USD | -72.33% |
| 2004 Q1 | 2.67 Million USD | 4960.0% |
| 2003 Q4 | -55 Thousand USD | -105.54% |
| 2003 Q2 | 1.03 Million USD | -18.67% |
| 2003 Q1 | 1.27 Million USD | 1348.86% |
| 2003 FY | 4.64 Million USD | 7140.91% |
| 2003 Q3 | 992 Thousand USD | -4.34% |
| 2002 Q4 | 88 Thousand USD | 105.39% |
| 2002 FY | -66 Thousand USD | -100.99% |
| 2002 Q3 | -1.63 Million USD | -903.94% |
| 2002 Q2 | 203 Thousand USD | -89.56% |
| 2002 Q1 | 1.94 Million USD | 101.24% |
| 2001 Q2 | 2.28 Million USD | 56.95% |
| 2001 Q4 | 966 Thousand USD | -34.91% |
| 2001 Q3 | 1.48 Million USD | -34.97% |
| 2001 Q1 | 1.45 Million USD | -68.72% |
| 2001 FY | 6.67 Million USD | -56.3% |
| 2000 Q3 | 5.65 Million USD | 57.01% |
| 2000 FY | 15.27 Million USD | 41.58% |
| 2000 Q4 | 4.64 Million USD | -17.82% |
| 2000 Q1 | 3.69 Million USD | 47.6% |
| 2000 Q2 | 3.6 Million USD | -2.36% |
| 1999 Q1 | 1.4 Million USD | -44.0% |
| 1999 FY | 10.79 Million USD | 7.9% |
| 1999 Q4 | 2.5 Million USD | 31.58% |
| 1999 Q3 | 1.9 Million USD | -26.92% |
| 1999 Q2 | 2.6 Million USD | 85.71% |
| 1998 Q1 | 4.1 Million USD | -19.61% |
| 1998 Q4 | 2.5 Million USD | -24.24% |
| 1998 Q3 | 3.3 Million USD | 13.79% |
| 1998 Q2 | 2.9 Million USD | -29.27% |
| 1998 FY | 10 Million USD | -48.45% |
| 1997 Q2 | 4.7 Million USD | -27.69% |
| 1997 Q3 | 5.5 Million USD | 17.02% |
| 1997 Q4 | 5.1 Million USD | -7.27% |
| 1997 FY | 19.4 Million USD | -31.21% |
| 1997 Q1 | 6.5 Million USD | 10.17% |
| 1996 FY | 28.2 Million USD | -5.69% |
| 1996 Q3 | 6.9 Million USD | -23.33% |
| 1996 Q4 | 5.9 Million USD | -14.49% |
| 1996 Q1 | 8.4 Million USD | 15.07% |
| 1996 Q2 | 9 Million USD | 7.14% |
| 1995 FY | 29.9 Million USD | 38.43% |
| 1995 Q4 | 7.3 Million USD | -48.95% |
| 1995 Q2 | 13.1 Million USD | 12.93% |
| 1995 Q3 | 14.3 Million USD | 9.16% |
| 1995 Q1 | 11.6 Million USD | 1.75% |
| 1994 FY | 21.6 Million USD | 30.83% |
| 1994 Q4 | 11.4 Million USD | -1.72% |
| 1994 Q3 | 11.6 Million USD | 16.0% |
| 1994 Q2 | 10 Million USD | 0.0% |
| 1993 FY | 16.51 Million USD | -15.16% |
| 1992 FY | 19.46 Million USD | -18.2% |
| 1991 FY | 23.79 Million USD | 42.63% |
| 1990 FY | 16.68 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Bio Medica Corporation | -193 Thousand USD | 3347.798% |
| Arrayit Corporation | 2.57 Million USD | -143.422% |
| Atlantic International Corp. | -154.23 Thousand USD | 4164.118% |
| Biocept, Inc. | -2.58 Million USD | 342.767% |
| Bioqual, Inc. | 7.42 Million USD | 15.626% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 276 Thousand USD | -2171.105% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 99.907% |
| HTG Molecular Diagnostics, Inc. | 1.79 Million USD | -249.384% |
| iMD Companies, Inc. | -23.63 Thousand USD | 26618.809% |
| IDenta Corp. | 662.97 Thousand USD | -845.473% |
| Interpace Biosciences, Inc. | 23.04 Million USD | 72.798% |
| Integrative Health Technologies, Inc. | 77.57 Thousand USD | -7980.663% |
| InVitro International | 635.98 Thousand USD | -885.597% |
| Lumos Diagnostics Holdings Limited | 6.56 Million USD | 4.491% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 1.09 Million USD | -473.656% |
| NovelStem International Corp. | 12 Thousand USD | -52135.425% |
| Optigenex Inc. | -102.96 Thousand USD | 6187.69% |
| PharmChem, Inc. | 3.9 Million USD | -60.544% |
| Proteome Sciences plc | 2.09 Million USD | -198.968% |
| Response Genetics, Inc | 3.94 Million USD | -59.012% |
| RushNet, Inc. | 1.1 Million USD | -467.46% |
| ScreenPro Security Inc. | 856.57 Thousand USD | -631.782% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | -403.74 Thousand USD | 1652.52% |
| Todos Medical Ltd. | 4.31 Million USD | -45.435% |